EBITDA was at Rs 152 crores showing a decline of 2.3 per cent, in the same quarter
Insecticides(India) Limited (IIL), announced its financial results for the fiscal quarter and full-year ending March 31, 2021.
In FY2021 YoY, the revenue from operations was at Rs 1,420 crore, registering a growth of 4.2 per cent. EBITDA was at Rs 152 crore, decline of 2.3 per cent. EBITDA margin was at 10.7 per cent compared to 11.4 per cent. The company registered a PAT of Rs 93 crore, showing a growth of 8.6 per cent. The PAT margin was at 6.5 per cent compared to 6.3 per cent. The company continued its deleveraging strategy and reduced its net debt by Rs 92 crore during the year. A total dividend of Rs 2 per share i.e. 20 per cent on face value, in Q3FY21 was announced.
In Q4 FY2021 YoY, revenue from operations was at Rs 256 crore, showing a growth of 7.1 per cent. EBITDA was at Rs 29 crore, with margins of 11.2 per cent compared to (1.0) per cent. PAT of Rs 22 crore was registered, with margins of 8.5 per cent compared to (3.1) per cent.
Rajesh Agarwal, MD, IIL said, “We have launched seven new products in FY21 for improving product mix, which has received positive response from the market and contributed Rs 27.4 crores to net sales during the year. I am also pleased to announce that Lethal Granules and Tadaaki have started substituting Thimet sales during the year and have registered annual sales of Rs. 56.5 crores and is expected to contribute good growth in the coming year. In addition, we are targeting to launch Hachiman, a patented herbicide mixture with Nissan Japan which is a part of our plan to launch five to six new value-added products during the year. Management team is fully equipped and committed to driving the growth as registration of new products, improving product mix and increasing brand business will help company to scale new heights.”
